Ewan Cobran, Ph.D.

Clinical and Administrative Pharmacy, Athens
Assistant Professor

Clinical and Administrative Pharmacy, Athens

Education

Postdoctoral Fellowship, Cancer Health Disparities, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center,  2014

Doctor Pharmaceutical Sciences, Howard University, College of Pharmacy 2012

Bachelor of Science, University of Florida, College of Health and Human Performance 2006

Honors, Awards, and Achievements
  • National Cancer Institute Cancer Prevention Program, Summer Curriculum in Cancer Prevention and Control – Molecular Prevention Scholar, 2019
  • Georgia Clinical & Translational Science Alliance (CTSA), KL2-Mentored Clinical and Translational Research Scholar, 2019-2021
  • Vice President for Academic Affairs & Provost at the University of Georgia, International Travel Award, 2018
  • Prostate Cancer Transatlantic Consortium International Travel Award, 2018
  • National Cancer Institute Cancer Prevention Program, Summer Curriculum in Cancer Prevention and Control Scholar, 2017
  • University of Oxford, Summer Scholar in Real World Data Epidemiology, Center for Statistics in Medicine (CSM), Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Musculoskeletal Pharmaco- and Device Epidemiology Group, 2017
  • Lilly Teaching Fellow, University of Georgia, Center for Teaching Learning, 2017-2019
  • Geographic Management of Cancer Health Disparities Programs (GMaP) Region 2 Scholar – Navigate Your Way to a K-Award, Targeted Training Workshop funded by the National Cancer Institute, 2016
  • National Institute on Minority Health and Health Disparities, Translational Health Disparities Scholar, 2015
Affiliations
Research Interests

My research interests are health services research, comparative effectiveness, health disparities, cancer screening, prevention, outcomes, fatalism, survivorship, community-based participatory research, patterns of care, nativity, and large data analysis.

Selected Publications

Peer-reviewed Publications

Alwhaibi A, Kolhe R, Gao F, Cobran EK, Somanath PR. (2019). Genome Atlas Analysis based Profiling of Akt Pathway Genes in the Early and Advanced Human Prostate Cancer. (Accepted).

 Cobran EK, Young NH, Chen RC, Chen X, Reeves J, Godley PA, Shah S (2018). Race and Timing of Androgen Deprivation Therapy among Men with Metastatic Prostate Cancer. Journal of the National Medical Association. S0027-9684(18)30168-8. doi: 10.1016/j.jnma.2018.10.005.

Shah S, Cobran EK, Young H. (2018). An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer. Journal of Pharmaceutical Health Services Research. doi: 1111/jphs.12248.

Shah S, Young H, Cobran EK. (2018). Comparative Effectiveness of Conservative Management versus Cryotherapy in Localized Prostate Cancer Patients. American Journal of Men’s Health. 12(5):1681-1691. doi: 10.1177/1557988318781731.

Shah S, Wei H, Jayawardhana J, Perri M, Cobran EK, & Young H. (2017). Cost utility analysis of Methylphenidate and Amphetamine/Dexamphetamine in adults with Attention-deficit hyperactivity disorder. Journal of Pharmaceutical Health Services Research. doi:10.1111/jphs.12173.

Cobran EK, Merino Y, Roach B, Bigelow SM, & Godley PA (2017). A feasibility study of the independent specialty medical advocate model of patient navigation on intermediate health outcomes in newly diagnosed cancer patients. Journal of Oncology Navigation & Survivorship. 8(10):462-470

Cobran EK, Hall JN, & Aiken W. (2017). African-American and Caribbean-born men’s perceptions of prostate cancer fear and facilitators for screening behavior: A pilot study. Journal of Cancer Education. doi:10.1007/s13187-017-1167-x.

Cobran EK, Chen RC, Overman R, Meyer AM, Kuo M, Sturmer T, Sheets N, Goldin GH, Pen D, Godley PA, Carpenter WR. (2016). Racial Disparities in Diffusion of Intensity-Modulated Radiation Therapy for Localized for Prostate Cancer. Am J Men’s Health. doi: 10.1177/1557988314568184.

Cobran EK, Wutoh AK, Lee E, Odedina F, Ragin C, Aiken W, and Godley P. (2014). Perceptions of Prostate Cancer Fatalism and Screening Behavior Between United States-born and Caribbean-born Black Males. J Immigr Minor Health. 16(3):394-400.

Pen D, Stitzenberg K, Cobran EK, Godley PA. (2014). Provider-based Research Network Demonstrate Greater Hospice Use for Minority Patients with Lung Cancer. J Oncol Pract. 10(4):e182-90.

Conference Presentations: Podium and Poster

Cobran EK, Young HN, Shah S. (2019). The Impact of Cryotherapy Compared to Conservative Management on Newly Diagnosed Mental Health Disorders in Men with Localized Prostate Cancer. Southeastern Symposium on Mental Health

Wei H, Zhuo Chen, Cobran EK. (2018). Perceived Cancer Risk and Evaluation of Public Awareness of Direct-to-Consumer Genetic Testing in the United States. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 23rd Annual Meeting

Shah S, Young HN, Cobran EK. (2018). An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 23rd Annual Meeting

Wei H, Zhuo Chen, Cobran EK. (2018). Financial Impact and Experience with General Medical Services Among Cancer Survivors in the United States. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 23rd Annual Meeting

Shah S, Cobran EK, Young H. (2017). The Impact of Cryotherapy and Conservative Management on Depression and Anxiety Disorders in Men with Prostate Cancer. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 22nd Annual Meeting

Kanchanasuwan, S, Cobran EK, Young H. (2016). Predicting hospital readmissions using the LACE index: Results from the Medical Expenditure Panel Survey. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 21st Annual Meeting

Cobran EK, Godley PA. (2015). Social Determinants for Diffusion of Intensity-Modulated Radiation Therapy Compared to Conformal Radiotherapy for Localized Prostate Cancer. American Pharmacists Association (APhA) Annual Meeting & Exposition, March 27-30, 2015, in San Diego, CA

Cobran EK, Godley PA, Carpenter W. (2015). Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. 10th Annual University of Alabama at Birmingham Health Disparities Research Symposium. Birmingham, Alabama

Grant Support

National Center for Advancing Translational Sciences – $422,718.00

Research Supplements to Promote Diversity in Health-Related Research (PA-18-906)

“Facilitators and Barriers to the Comprehension for the Application of Genomic Technology for Prognostic Testing among Rural White and African-American Men with Localized Prostate Cancer” 04/23/2019 – 01/08/2021 (Role: Principal Investigator)

Winship Cancer Institute of Emory University – $12,500.00

“Development and Pilot Test of a Video-based Educational Tool for The Comprehension of Common Prognostic Genomic Terminology for Prostate Cancer” 06/01/2019 – 06/30/2020 (Role: Principal Investigator)

Owens Institute for Behavioral Research, University of Georgia – $5,000.00

“Utilization of Prognostic Genetic Testing for Localized Prostate Cancer” 07/01/2018 – 06/30/2019 (Role: Principal Investigator)

Lilly Fellow Program, Center for Teaching and Learning, University of Georgia – $2,000.00

“Instructional Improvement in Pharmaceutical Epidemiology and Health Outcomes Research for Doctoral and Pharmacy Students” 08/01/2018 – 06/30/2019 (Role: Principal Investigator)

 American Cancer Society – $40,000.00                 

“Quality of Life, Racial Differences, and Risk of Androgen Deprivation Therapy Associated Diabetes, MI, and CVD during Treatment for Advance Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER) Linked Medicare Part D and Medicare Health Outcomes Survey Analysis” 07/01/2015 – 10/31/2017, (Role: Principal Investigator)

University of Georgia College of Pharmacy Randy Ellison Cancer Research Fund – $1,500.00

“Barriers to the Utilization of Preventive Health Services and Adoption of Healthy Lifestyle Behaviors among Postmenopausal Breast Cancer Survivors” 09/11/2015 – 10/31/2017 (Role: Co-Principal Investigator)

University of Georgia Clinical and Translational Research Unit – $30,000.00

Effect of a Physical Activity and Healthy Eating Intervention Compared to a Mindful Eating Intervention on Biomarkers of Cancer Prognosis in Overweight and Obese Breast Cancer Survivors” 12/15/2015 – 10/31/2017 (Role: Co-Principal Investigator)

 Navigate Cancer Foundation – $6,375.00

“Associations Between the Independent Specialty Medical Advocate Model of Patient Advocacy Services and Intermediate Patient Health Outcomes in Prostate Cancer Patients” 03/01/2013 – 12/01/2015 (Role: Principal Investigator)

North Carolina Translation & Clinical Science Institute – $2,000.00

“Evaluating Racial Differences in Survival and Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer Using the Surveillance, Epidemiology, and End Results Cancer Registry and Medicare Claims Database” 07/01/2013 – 6/01/2014 (Role: Principal Investigator)

National Cancer Institute – $164,158.00

“Cancer Health Disparities Training Program (T32), University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center – 5T32CA128582-043” 09/01/2012 – 08/01/2014 (Role: Postdoctoral Fellow)